Bioteque Corporation (TPEX:4107)
Taiwan · Delayed Price · Currency is TWD 120.00
+1.00 (0.84%)
Jan 22, 2026, 12:41 PM CST
Bioteque Market Cap
Bioteque has a market cap or net worth of 8.25 billion as of January 21, 2026. Its market cap has decreased by -2.46% in one year.
Market Cap
8.25B
Enterprise Value
7.37B
Revenue
2.07B
Ranking
n/a
PE Ratio
15.99
Stock Price
120.00
Market Cap Chart
Since November 3, 2004, Bioteque's market cap has increased from 442.84M to 8.25B, an increase of 1,762.20%. That is a compound annual growth rate of 14.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 8.25B | -1.24% |
| Dec 31, 2025 | 8.35B | -2.43% |
| Dec 31, 2024 | 8.56B | 12.27% |
| Dec 29, 2023 | 7.62B | -1.35% |
| Dec 30, 2022 | 7.73B | -2.62% |
| Dec 30, 2021 | 7.93B | -13.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Center Laboratories | 31.50B |
| Lumosa Therapeutics | 31.25B |